# Gynecologic Cancers — Year in Review Series on Relevant New Datasets and Advances Page: https://stenobird.com/podcast/gynecologic-oncology-update-612940/gynecologic-cancers-year-in-review-series-on-relevant-new-datasets-and-advances Text version: https://stenobird.com/podcast/gynecologic-oncology-update-612940/gynecologic-cancers-year-in-review-series-on-relevant-new-datasets-and-advances.md Podcast: [Gynecologic Oncology Update](https://stenobird.com/podcast/gynecologic-oncology-update-612940) Published: 2025-08-02T12:00:00+00:00 Episode link: https://gynecologic-oncology.captivate.fm/episode/5490-yir2024-gyn Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/0bcca8a9-1162-4411-8903-41686b5084b9.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/gynecologic-cancers-year-in-review-series-on-relevant-new-datasets-and-advances Duration seconds: 3574 ## Resource Prof Susana Banerjee from The Institute of Cancer Research in London and Dr Ursula Matulonis from Dana-Farber Cancer Institute in Boston discuss important efficacy and safety data from the past year related to the management of ovarian, endometrial and cervical cancers. CME information and select publications here . ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/gynecologic-cancers-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/gynecologic-oncology-update-612940/gynecologic-cancers-year-in-review-series-on-relevant-new-datasets-and-advances.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.